SynAct Pharma refines development strategy and extends financial runway through 2026
5 juni, 15:40
5 juni, 15:40
On June 4, SynAct Pharma hosted a Capital Markets Day to present its refined development strategy, including the launch of development initiatives in polymyalgia rheumatica. On the same day, the company announced a directed share issue of approximately SEK 37 million, along with a SEK 30 million credit facility – together securing a financial runway through the end of 2026.
Read the article at biostock.se
https://biostock.se/2025/06/synact-pharma-refines-development-strategy-and-extends-financial-runway-through-2026/
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.
5 juni, 15:40
On June 4, SynAct Pharma hosted a Capital Markets Day to present its refined development strategy, including the launch of development initiatives in polymyalgia rheumatica. On the same day, the company announced a directed share issue of approximately SEK 37 million, along with a SEK 30 million credit facility – together securing a financial runway through the end of 2026.
Read the article at biostock.se
https://biostock.se/2025/06/synact-pharma-refines-development-strategy-and-extends-financial-runway-through-2026/
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.
Analyser

Aktieråd


SBB

Inflationen
Analyser

Aktieråd


SBB

Inflationen
1 DAG %
Senast

Stockholmsbörsen
12 december, 17:47
Börsen föll tillbaka – stänger veckan rött
Castellum
12 december, 17:27
Castellums VD shoppar loss
Nordea Bank
12 december, 17:02
Storbankerna är dyrare än vanligt – vi slopar köpråden
blankning
12 december, 16:41
Här är de mest blankade aktierna just nu
Coffee Stain Group B
12 december, 14:25
Analys: Uppsidan lockar i Embracers avknoppning
OMX Stockholm 30
1 DAG %
Senast
2 821,01